Increased Galectin-1 Expression in Thymic Epithelial Tumors

Jonathan Riess, Christina S. Kong, Robert B. West, Sukhmani K. Padda, Joel W. Neal, Heather A. Wakelee, Quynh Thu Le

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Thymic malignancies are rare tumors where lack of preclinical models adversely affect development of new therapies. Galectin-1 is an important protein in cancer involved in maintaining an immunosuppressive environment. This study examined galectin-1 expression in a large thymic epithelial tumor issue microarray and found elevated expression compared to benign thymus controls. Galectin-1 is a potential therapeutic target in thymic malignancies.

Original languageEnglish (US)
JournalClinical Lung Cancer
DOIs
StatePublished - Jan 1 2019

Fingerprint

Galectin 1
Neoplasms
Immunosuppressive Agents
Thymus Gland
Thymic epithelial tumor
Therapeutics
Proteins

Keywords

  • Thymic malignancy
  • Tumor microenvironment

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Riess, J., Kong, C. S., West, R. B., Padda, S. K., Neal, J. W., Wakelee, H. A., & Le, Q. T. (2019). Increased Galectin-1 Expression in Thymic Epithelial Tumors. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2018.12.005

Increased Galectin-1 Expression in Thymic Epithelial Tumors. / Riess, Jonathan; Kong, Christina S.; West, Robert B.; Padda, Sukhmani K.; Neal, Joel W.; Wakelee, Heather A.; Le, Quynh Thu.

In: Clinical Lung Cancer, 01.01.2019.

Research output: Contribution to journalArticle

Riess, Jonathan ; Kong, Christina S. ; West, Robert B. ; Padda, Sukhmani K. ; Neal, Joel W. ; Wakelee, Heather A. ; Le, Quynh Thu. / Increased Galectin-1 Expression in Thymic Epithelial Tumors. In: Clinical Lung Cancer. 2019.
@article{910979b53512497a91e808c4e8c03e6b,
title = "Increased Galectin-1 Expression in Thymic Epithelial Tumors",
abstract = "Thymic malignancies are rare tumors where lack of preclinical models adversely affect development of new therapies. Galectin-1 is an important protein in cancer involved in maintaining an immunosuppressive environment. This study examined galectin-1 expression in a large thymic epithelial tumor issue microarray and found elevated expression compared to benign thymus controls. Galectin-1 is a potential therapeutic target in thymic malignancies.",
keywords = "Thymic malignancy, Tumor microenvironment",
author = "Jonathan Riess and Kong, {Christina S.} and West, {Robert B.} and Padda, {Sukhmani K.} and Neal, {Joel W.} and Wakelee, {Heather A.} and Le, {Quynh Thu}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.cllc.2018.12.005",
language = "English (US)",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",

}

TY - JOUR

T1 - Increased Galectin-1 Expression in Thymic Epithelial Tumors

AU - Riess, Jonathan

AU - Kong, Christina S.

AU - West, Robert B.

AU - Padda, Sukhmani K.

AU - Neal, Joel W.

AU - Wakelee, Heather A.

AU - Le, Quynh Thu

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Thymic malignancies are rare tumors where lack of preclinical models adversely affect development of new therapies. Galectin-1 is an important protein in cancer involved in maintaining an immunosuppressive environment. This study examined galectin-1 expression in a large thymic epithelial tumor issue microarray and found elevated expression compared to benign thymus controls. Galectin-1 is a potential therapeutic target in thymic malignancies.

AB - Thymic malignancies are rare tumors where lack of preclinical models adversely affect development of new therapies. Galectin-1 is an important protein in cancer involved in maintaining an immunosuppressive environment. This study examined galectin-1 expression in a large thymic epithelial tumor issue microarray and found elevated expression compared to benign thymus controls. Galectin-1 is a potential therapeutic target in thymic malignancies.

KW - Thymic malignancy

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85061433479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061433479&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2018.12.005

DO - 10.1016/j.cllc.2018.12.005

M3 - Article

C2 - 30773448

AN - SCOPUS:85061433479

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

ER -